ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

RNAZ TransCode Therapeutics Inc

0,71
-0,0201 (-2,75%)
Pré-mercado
Última atualização: 10:11:09
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
TransCode Therapeutics Inc RNAZ NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,0201 -2,75% 0,71 10:11:09
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,7301
mais cotações »

Notícias Recentes

Data Hora Fonte Título
13/05/202409:30GLOBETransCode Therapeutics Open Letter to Shareholders
15/04/202410:00GLOBETransCode Therapeutics Announces FDA Clearance To Initiate..
03/04/202410:10GLOBETransCode Therapeutics Reports 2023 Results; Provides..
28/03/202409:30GLOBETransCode Therapeutics Announces Appointment of Daniel..
11/03/202410:00GLOBETransCode Therapeutics and Akribion Genomics Report Progress..
06/03/202418:15GLOBETransCode Therapeutics To Present At 2024 RNA Leaders Europe..
20/02/202410:00GLOBETransCode Therapeutics Reports Publication of United States..
31/01/202418:05GLOBENasdaq Determines TransCode Therapeutics Compliance with..
29/01/202410:30GLOBETransCode Therapeutics and Debiopharm Announce Collaboration..
22/01/202418:45GLOBETransCode Therapeutics Announces Closing of $7.25 Million..
18/01/202415:27GLOBETransCode Therapeutics Announces Pricing of $7.25 Million..
12/01/202418:05GLOBETransCode Therapeutics Reports Further Restructuring to..
11/01/202410:00GLOBETransCode Therapeutics Announces 1-for-40 Reverse Stock..
04/01/202410:05GLOBETransCode Therapeutics Publishes Open Letter Outlining..
12/12/202310:30GLOBETransCode Therapeutics Reports Positive Pre-Clinical Results..
05/12/202311:00GLOBETransCode Therapeutics To Present Phase 0 Data at 2023 San..
04/12/202318:10GLOBETransCode Therapeutics Announces Closing of $1.2 Million..
30/11/202316:53GLOBETransCode Therapeutics Announces $1.2 Million Registered..
14/11/202318:30GLOBETransCode Therapeutics Reports Third Quarter 2023 Results;..
31/10/202323:20APSBiotech Shares Bid Up Following Public Offering Cancellation
30/10/202317:33GLOBETransCode Therapeutics Withdraws Public Offering
27/10/202309:00GLOBENasdaq Panel Grants TransCode Therapeutics Extension for..
26/10/202317:19GLOBETransCode Therapeutics Announces Public Offering of Common..
26/10/202309:00GLOBETransCode Therapeutics Announces Prolonged Survival in..
24/10/202309:00GLOBETransCode Therapeutics Announces Preliminary Clinical..
16/10/202309:00GLOBETransCode Therapeutics Reports Successful Treatment of..
28/09/202317:02GLOBETransCode Therapeutics Announces Closing of $8.5 Million..
25/09/202321:01GLOBETransCode Therapeutics Announces Pricing of $8 Million..
25/09/202309:30GLOBETransCode Therapeutics Announces Positive Pre-Clinical..
23/08/202309:00GLOBETransCode Therapeutics Announces First Subject Dosed with..
14/08/202317:45GLOBETransCode Therapeutics Reports Second Quarter 2023 Results;..
31/07/202308:00GLOBETransCode Therapeutics Announces Positive Results in..
05/07/202308:00GLOBETransCode Therapeutics CEO Letter to Shareholders
22/06/202308:00GLOBETransCode Therapeutics Announces Publication of New Data..
09/06/202317:05GLOBETransCode Therapeutics Announces Closing of $7 Million..
06/06/202318:29GLOBETransCode Therapeutics Announces Pricing of $7 Million..
06/06/202317:01GLOBETransCode Therapeutics Reports Positive Preclinical Results..
22/05/202308:00GLOBETransCode Therapeutics Announces 1-for-20 Reverse Stock..

Seu Histórico Recente

Delayed Upgrade Clock